Trial intelligence / Profile preview

Dexmedetomidine as an Adjuvant to Bupivacaine-Fentanyl in Spinal Analgesia for Normal Labour

NCT07332130Phase 1Not yet recruiting

Sponsor
Minia University Hospital
Start
Dec 2025
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of dexmedetomidine in labor pain (2 arms), sponsored by Minia University Hospital. Primary endpoints: Numeric Pain Intensity Score and Duration of sensory blockade. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

labor pain

Beyond the preview

Go deeper on NCT07332130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07332130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call